BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 340757)

  • 1. [Controlled study oflidoflazine in ischemic heart disease].
    Demin AA; Balashov VA
    Kardiologiia; 1977 Dec; 17(12):125. PubMed ID: 340757
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study.
    De Geest H; Kesteloot H; Piessens J
    Acta Cardiol Suppl; 1979; (24):7-116. PubMed ID: 122040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ambulatory treatment experience with lidoflazine in ischemic heart disease].
    Pmerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI
    Kardiologiia; 1980 Jul; 20(7):109-10. PubMed ID: 7401433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lidoflazine and dysrhythmia (author's transl)].
    Bergouignan J; Lefebvre D; Levol B; Ory J
    Ann Cardiol Angeiol (Paris); 1976; 25(2):155-60. PubMed ID: 1267401
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of lidoflazine as an anti-anginal drug.
    Vohra JK; Sloman JG
    Cardiology; 1973; 58(4):209-19. PubMed ID: 4206284
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients].
    Lehmann HU; Ghabussi P; Hochrein H
    Med Welt; 1977 Feb; 28(8):386-90. PubMed ID: 321914
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of lidoflazin in the treatment of ischemic heart disease].
    Fomina AA; Mironova KA; Glomozda NIa; Klimovich MD
    Vrach Delo; 1977 Mar; (3):68-71. PubMed ID: 855300
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
    Liu GS; Borgers M; Xhonneux R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease].
    Teichmann W; Vogel HC; Schäbitz J; Schmeisser M; Lukesch KH
    Z Gesamte Inn Med; 1976 Mar; 31(6):161-6. PubMed ID: 941465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
    Lehmann H; Hochrein H
    Med Klin; 1976 Jan; 71(5):189-96. PubMed ID: 814396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinium used in the treatment of chronic ischaemic cardiac failures.
    Teichmann W; Schäbitz J; Schmeisser M; Vogel H; Lukesch K
    Ther Hung; 1975; 23(2):43-9. PubMed ID: 810909
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of lidoflazine on ventricular ectopic activity in chronic ischaemic heart disease.
    Myburgh DP
    S Afr Med J; 1975 Nov; 49(50):2087-90. PubMed ID: 1198246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postinfarction exercise capacity after lidoflazine treatment or physical training.
    Degré S; Lenaers A; Messin R; Vandermoten P; Salhadin P; Limage M; Denolin H
    Cardiology; 1979; 64(1):35-47. PubMed ID: 365332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients.
    Meilink-Hoedemaker LJ; Pool J; Muste-Heijns MM
    Acta Med Scand; 1976; 199(1-2):17-23. PubMed ID: 766572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidoflazine and physical training in the treatment of stable angina pectoris.
    Ferguson RJ; Côté P; Bourassa MG; Corbara F
    Clin Cardiol; 1979 Dec; 2(6):413-6. PubMed ID: 397017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection by lidoflazine during one-hour normothermic global ischemia.
    Daenen W; Flameng W
    Angiology; 1981 Aug; 32(8):543-51. PubMed ID: 7258731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-invasive examination of cardiac hemodynamics in an anginal coronary syndrome after long term treatment with lidoflazine].
    Dvorák I; Zemánková J; Bravený P; Blaha M; Dvorák M; Sedá L; Havlát F
    Vnitr Lek; 1981 Apr; 27(4):338-44. PubMed ID: 7027603
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
    Lehmann HU; Scholle J; Hochrein H
    MMW Munch Med Wochenschr; 1974 Nov; 116(46):2019-26. PubMed ID: 4141058
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-arrhythmic action of lidoflazine].
    Zini C; Domenici M
    Torace; 1976 Dec; 19(1-4):100-5. PubMed ID: 1052720
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dosed physical loading as a method of evaluating the results of treating ischemic heart disease].
    Ol'binskaia LI; Ovchinnikova LV
    Kardiologiia; 1972 Dec; 12(12):32-6. PubMed ID: 4196637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.